CUV 1.85% $13.28 clinuvel pharmaceuticals limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-27

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 578 Posts.
    lightbulb Created with Sketch. 84
    @turbo thanks for the useful analysis and I agree with it in a general sense, but can I just point out the 38% I quoted referred to Receipts From Customers (cash flow metric), and not Revenues (P&L metric). They are obviously closely related, but are not quite the same thing. RFCs are available quarterly, but Revenues are given only every 6 months. Over the same 9 year historical analysis, 31% of revenues have been seen in FY H1 with 69% in FY H2.

    Your point about strong growth at attractive valuations remains spot on.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$13.28
Change
-0.250(1.85%)
Mkt cap ! $664.8M
Open High Low Value Volume
$13.55 $13.62 $13.25 $1.157M 86.45K

Buyers (Bids)

No. Vol. Price($)
1 227 $13.28
 

Sellers (Offers)

Price($) Vol. No.
$13.42 228 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.